发明名称 SATURATED HETEROCYCLIC COMPOUND
摘要 <p>PROBLEM TO BE SOLVED: To obtain a new saturated heterocylcic compound useful for producing preventing agents or therapeutic agent for tachykinin intervened disease such as split personality, etc. SOLUTION: The compound is expressed in formula I (R<1> , R<2> , R<3> are each an aryl, etc.,; A is methylene, etc.,; B is single bond, a 1-4C alkylene, etc.,; D is O or S; E is a 1-6C alkylene, etc., G is a 1-4C alkylene, etc., L is a group having -N(R3 )-), etc., or its pharmacologically permissible salts or esters and other derivatives, e.g. 1- 2-[5-(3,4-dichlorophenyl)-3-[3,4,5 trimethoxybenzoyl]oxazolidin-5-yl]ethyl}-4-phenylpiperidine-4carboxylic acid amide. The compound of formula I is obtained by carrying out the reaction of the compound of formula II (R<8> is H or a protecting group) and the compound of formula III (Y is a halogen) in a solvent in the presence of a base such as triethylamine, etc., at -20 to 100 deg.C, and removing R<8> to obtain the compound of formula IV. Then carrying out the reaction of the compound of formula IV and the compound of formula V in a solvent such as C6 H14 , etc., in the presence of a base such as KI, etc., at 0 to 150 deg.C.</p>
申请公布号 JPH09235275(A) 申请公布日期 1997.09.09
申请号 JP19960321780 申请日期 1996.12.02
申请人 SANKYO CO LTD 发明人 NISHI TAKEHIDE;ISHIBASHI KIMIKI;NAKAJIMA KATSUYOSHI;FUKAZAWA TETSUYA;KURATA HITOSHI;YAMAGUCHI TAKESHI;ITO KAZUHIRO
分类号 C07D277/22;A61K31/421;A61K31/435;A61K31/445;A61K31/47;A61K31/495;A61K31/496;A61P1/00;A61P11/00;A61P11/06;A61P11/08;A61P17/00;A61P19/02;A61P25/00;A61P25/04;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P27/00;A61P27/02;A61P27/14;A61P27/16;A61P29/00;A61P37/00;A61P37/08;A61P43/00;C07D263/04;C07D263/06;C07D413/06;C07D413/12;C07D413/14;C07D417/06;C07D417/12;C07D417/14;C07D471/10;C07D491/107;C07D495/10;C07D498/10;(IPC1-7):C07D263/04 主分类号 C07D277/22
代理机构 代理人
主权项
地址